Sat 26 Oct 2024 ▪
3 min read
▪
by
▪
Event
Doliprane, the star medication against fever and pain, is making headlines due to its controversial sale to an American investment fund. The affair has sparked an outcry, particularly because of a one-time bonus of 200 million euros paid to its CEO.